Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel
OTCMKTS:BIOQ

Bioqual Q1 2025 Earnings Report

Bioqual logo
$33.00 0.00 (0.00%)
As of 09/25/2026
ProfileEarnings History

Bioqual EPS Results

Actual EPS
-$0.76
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bioqual Revenue Results

Actual Revenue
$11.77 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bioqual Announcement Details

Quarter
Q1 2025
Date
10/22/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Bioqual Earnings Headlines

BIOQUAL Presents Financial Results for Fiscal Year 2026
September 22, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260922682992/en/bioqual-presents-financial-results-for-fiscal-year-2026/
Bioqual (OTCMKTS:BIOQ) Releases Earnings Results
September 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31039633
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
 |  Awesomely (Ad)
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2026
April 21, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260421934317/en/bioqual-presents-unaudited-financial-results-for-third-quarter-of-fiscal-year-2026/
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026
January 22, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260122375204/en/bioqual-presents-unaudited-financial-results-for-second-quarter-of-fiscal-year-2026/
PETA files complaint over Mississippi monkey truck crash, citing animal welfare violations
November 7, 2025  |  msn.comhttps://www.msn.com/en-us/news/other/peta-files-complaint-over-mississippi-monkey-truck-crash-citing-animal-welfare-violations/ar-AA1Q1X5R
See More Bioqual Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bioqual? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioqual and other key companies, straight to your email.

About Bioqual

Bioqual (OTCMKTS:BIOQ), Inc. is a contract research organization that provides preclinical biomedical research services to pharmaceutical, biotechnology and government customers. The company specializes in infectious disease research and uses laboratory and animal models to support the development and evaluation of vaccines, therapeutics and diagnostic products.

Its services have included studies involving HIV, hepatitis, influenza, COVID-19 and other infectious diseases, as well as immunology, pharmacology and toxicology research. Bioqual also provides research support using nonhuman primate and other animal models, along with laboratory testing and related scientific services.

Based in the United States, Bioqual has historically served customers in the pharmaceutical, biotechnology and public-sector research communities. Publicly available information about its current leadership and operations is limited.

View Bioqual Profile
Earnings Tools